לבטיראצטם דקסל 250

Negara: Israel

Bahasa: Ibrani

Sumber: Ministry of Health

Bahan aktif:

LEVETIRACETAM

Tersedia dari:

DEXCEL PHARMA TECHNOLOGIES LTD

Kode ATC:

N03AX14

Bentuk farmasi:

טבליה

Komposisi:

LEVETIRACETAM 250 MG

Rute administrasi :

פומי

Jenis Resep:

מרשם נדרש

Diproduksi oleh:

DEXCEL LTD, ISRAEL

Kelompok Terapi:

LEVETIRACETAM

Area terapi:

LEVETIRACETAM

Indikasi Terapi:

Levetiracetam Dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.Levetiracetam Dexcel is indicated as adjunctive therapy:• In the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.• In the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.

Ringkasan produk:

א. התרופה האמורה תינתן לטיפול באפילפסיה. ב. מתן התרופה ייעשה לפי המלצת רופא מומחה בנוירולוגיה.

Tanggal Otorisasi:

2018-03-31

Selebaran informasi

(
)
"
-
1986
250
,
500 ,
750 ,
1000
,
(
Levetiracetam
)
250
,
500
,
750
1000
"
,
.
-
6
"
"
2
"
"
.
.
.
,
.
.
.
.
1
.
?

16
.

-
:

4
,
.

12
Juvenile myoclonic epilepsy
Idiopathic generalised epilepsy
.
:
.
2
.
:

)
(
(
)
(Pyrrolidone)
(
6
.)
: ,

.
.

,
.

/
.
-
.
.
.
:
,
,
,
,
.

) "
(
.

:
o
,
,
.
o
:
,
,
.
.
,
)
(
(
SCN8A
)
.
, - !
16
.
,
, , .
:

)
(
.
,
.

.
.
,
.
.)
(
.
,
.
.
,
,
,
.
,
.
.
.
.
,
.
.
.
,
.
-
1
(
23
) "
,
."
"
750
Sunset yellow (E110)
,
.
3
.
?
.
.
. .
)
(
.
-
2
.
.
,
.
.
.

.
.

.
,
.
:
,
,
,
,
.
,
.
.
.
,
.
,
.
! . . ,
.
4
.
,
.
.
.
:

,
.
)
(
.

,
,
(
s oedema
’
Quincke
)
.

,
(
)
(
DRESS
)
.

,
,
,
,
,
.
.

(
,
)
(
)
.

,
,
,
(
-
)
'
.

-
30%
(
)
.

,
,
(
)
,)
(
,
.
.
,
,
,
.
,
,
.
.
(
)
:


,
(
1-10
100
)
:

(
)

,
,
,
,

,
,
,
(
-
)
,

)
(


,
,
,
,


(
1-10
1,000
)
:

,


,
,
,
,
,
,
,
,
(
)

,
,)
(
/
(
)
,
)
(
,

,

/

,
,

,

(
1-10
10,000
:)



(
DRESS
,
[
,]
Quincke
’
s oedema
[
,
,
)]


,
,
(
,
)


)
"
"
(


,
)
(
,
,
(
)

) "
(

(
)

,
(
)


(
,
)
)
(
,
,
,
,
(
-
)
'
,
-
30%
(
)

(
)
.


(
,
,
,
,
.)
.
(
10,000
:)

.)
( ,
. ,
"
"
(
www.health.gov.il
)
,
:
https://sideeffects.health.gov.il
5
.
?

!
/
.
.

.
.

:
-
25°C
.
6
.
,
:
Croscarmellose sodium, microcrystalline cellulose, povidone, glyceryl
behenate, polyvinyl
alcohol partially hydrolyzed, titanium dioxide (E171), macrogol 3350,
talc, silica colloidal
anhydrous, carnauba wax.
250
Indigo carmine lake (E132)
.
500
Yellow iron oxide (E172)
.
750
Sunset yellow (E110)
,
Red iron oxide (E172)
.
:
250
:
,
,
,
.
500
:
,
,
,
.
750
:
,
,
,
.
1000
:
,
,
,
.
:
60
.
:
"
,
'
1
,
3060000
,
2023
.
:
250
:
149-63-33519-00
500
:
149-64-33518-00
750
: 149-65-33520-00
1000
:
149-66-33514-00
,
.
,
.
:
"
'
21
,
9548402
,